Published in Biochim Biophys Acta on July 22, 1975
Sphingosine 1-phosphate signalling in mammalian cells. Biochem J (2000) 3.33
Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. Biochim Biophys Acta (2008) 2.25
Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol (2004) 1.64
Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death. J Exp Med (2000) 1.19
Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases. Br J Pharmacol (2011) 1.15
Ceramide function in the brain: when a slight tilt is enough. Cell Mol Life Sci (2012) 1.12
Cannabinoid-receptor-independent cell signalling by N-acylethanolamines. Biochem J (2001) 1.06
Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. J Clin Invest (2000) 1.03
Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity. Sci Rep (2013) 1.02
The complications of promiscuity: endocannabinoid action and metabolism. Br J Pharmacol (2007) 1.02
Molecular targeting of acid ceramidase: implications to cancer therapy. Curr Drug Targets (2008) 1.01
A simple fluorogenic method for determination of acid ceramidase activity and diagnosis of Farber disease. J Lipid Res (2010) 0.94
Stress-induced generation of N-acylethanolamines in mouse epidermal JB6 P+ cells. Biochem J (2000) 0.94
Substrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controls. Biochem J (1982) 0.90
Potent inhibition of Acid ceramidase by novel B-13 analogues. J Lipids (2010) 0.86
Activation of bacterial ceramidase by anionic glycerophospholipids: possible involvement in ceramide hydrolysis on atopic skin by Pseudomonas ceramidase. Biochem J (2002) 0.85
Effects of tumour necrosis factor-alpha on left ventricular function in the rat isolated perfused heart: possible mechanisms for a decline in cardiac function. Br J Pharmacol (1999) 0.84
Betamethasone modulation of sphingomyelin hydrolysis up-regulates CTP:cholinephosphate cytidylyltransferase activity in adult rat lung. Biochem J (1996) 0.82
Endothelial Nogo-B regulates sphingolipid biosynthesis to promote pathological cardiac hypertrophy during chronic pressure overload. JCI Insight (2016) 0.81
Novel chemotherapeutic drugs in sphingolipid cancer research. Handb Exp Pharmacol (2013) 0.80
Differential scanning calorimetry of chain-melting phase transitions of N-acylphosphatidylethanolamines. Biophys J (1997) 0.80
Improved synthesis of a fluorogenic ceramidase substrate. Bioorg Med Chem (2010) 0.79
Distribution and properties of neutral ceramidase activity in rat intestinal tract. Dig Dis Sci (2001) 0.77
The complete nucleotide sequence of the tobacco chloroplast genome: its gene organization and expression. EMBO J (1986) 19.59
Isolation of rat liver plasma membranes. Use of nucleotide pyrophosphatase and phosphodiesterase I as marker enzymes. J Cell Biol (1970) 3.77
Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex (2000) 3.69
Murine CD1d-restricted T cell recognition of cellular lipids. Immunity (2000) 3.57
Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells. Proc Natl Acad Sci U S A (1981) 2.83
Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci U S A (1996) 2.67
Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nat Genet (1995) 2.62
MR findings in adult-onset adrenoleukodystrophy. AJNR Am J Neuroradiol (1995) 2.42
Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med (2000) 2.30
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann Oncol (2008) 2.29
A putative gene of tobacco chloroplast coding for ribosomal protein similar to E. coli ribosomal protein S19. Nucleic Acids Res (1983) 2.26
A unified nomenclature for peroxisome biogenesis factors. J Cell Biol (1996) 2.25
MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity (2001) 2.19
Visual evoked potentials in adrenoleukodystrophy: a trial with glycerol trioleate and Lorenzo oil. Ann Neurol (1993) 2.07
Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann Neurol (1999) 2.06
Do anger and aggression affect carotid atherosclerosis? Stroke (1993) 1.96
Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology (2003) 1.92
Genes for the eight ribosomal proteins are clustered on the chloroplast genome of tobacco (Nicotiana tabacum): similarity to the S10 and spc operons of Escherichia coli. Proc Natl Acad Sci U S A (1986) 1.83
Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy. Ann Neurol (1984) 1.83
Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. Neurology (1981) 1.81
Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy. Neurology (2005) 1.77
Complete nucleotide sequence of the chloroplast genome from the green alga Chlorella vulgaris: the existence of genes possibly involved in chloroplast division. Proc Natl Acad Sci U S A (1997) 1.75
Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc Natl Acad Sci U S A (1984) 1.75
Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol (2001) 1.71
Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts. Ann Neurol (1980) 1.71
Hyperornithinemia, hyperammonemia, and homocitrullinuria. A new disorder of amino acid metabolism associated with myoclonic seizures and mental retardation. Am J Dis Child (1969) 1.65
STAT6 deficiency in a mouse model of allergen-induced airways inflammation abolishes eosinophilia but induces infiltration of CD8+ T cells. Clin Exp Allergy (1999) 1.64
The peroxisome biogenesis disorder group 4 gene, PXAAA1, encodes a cytoplasmic ATPase required for stability of the PTS1 receptor. EMBO J (1996) 1.62
The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity (1998) 1.59
Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab (1988) 1.59
The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis. N Engl J Med (1984) 1.56
Evolution and mechanism of translation in chloroplasts. Annu Rev Genet (1998) 1.50
Rhythmic Cl- current and physiological roles of the intestinal c-kit-positive cells. Pflugers Arch (1995) 1.49
Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes. Am J Med Genet (1986) 1.47
Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes. Am J Med Genet (1998) 1.47
Kinetics of apoptosis in the lung of mice with allergic airway inflammation. Clin Exp Allergy (1998) 1.47
Clonal V alpha 12.1+ T cell expansions in the peripheral blood of rheumatoid arthritis patients. J Exp Med (1993) 1.47
Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells. Hum Genet (1992) 1.46
ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat (2001) 1.45
Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders. Nat Genet (1997) 1.44
Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells. Eur J Immunol (2000) 1.43
Possible predictive markers of immunotherapy in esophageal cancer: retrospective analysis of a randomized study. The Cooperative Study Group for Esophageal Cancer in Japan. Cancer Invest (1995) 1.42
The CD1 family of lipid antigen-presenting molecules. Immunol Today (1998) 1.42
Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. J Cell Sci (1995) 1.40
Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids. Johns Hopkins Med J (1982) 1.39
Mitochondrial encephalomyopathy with elderly onset of stroke-like episodes. Intern Med (1996) 1.39
Prolonged survival and remyelination after hematopoietic cell transplantation in the twitcher mouse. Science (1984) 1.39
Increased urinary beta 2-microglobulin in cadmium exposure: dose-effect relationship and biological significance of beta 2-microglobulin. Environ Health Perspect (1979) 1.37
Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol (1998) 1.35
Frequent alterations of visual pigment genes in adrenoleukodystrophy. Am J Hum Genet (1988) 1.32
Identification of PEX10, the gene defective in complementation group 7 of the peroxisome-biogenesis disorders. Am J Hum Genet (1998) 1.31
Metabolic control of peroxisome abundance. J Cell Sci (1999) 1.31
Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defect. Am J Hum Genet (1993) 1.29
The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol (1992) 1.27
Adrenoleukodystrophy: studies of the phenotype, genetics and biochemistry. Johns Hopkins Med J (1980) 1.23
cDNA structure, expression and nucleic acid-binding properties of three RNA-binding proteins in tobacco: occurrence of tissue-specific alternative splicing. Nucleic Acids Res (1993) 1.22
Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes. Pediatr Res (1984) 1.21
Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer. Br J Cancer (2005) 1.21
The solubilization and gel electrophoresis of membrane enzymes by use of detergents. Biochim Biophys Acta (1970) 1.21
Linkage of adrenoleukodystrophy to a polymorphic DNA probe. Ann Neurol (1987) 1.20
Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Jpn J Ophthalmol (1999) 1.20
A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci U S A (1997) 1.20
Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol (2001) 1.19
Apparent biochemical homozygosity in two obligatory heterozygotes for metachromatic leukodystrophy. J Pediatr (1976) 1.19
Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J Neuropathol Exp Neurol (2000) 1.17
Solubilization and polyacrylamide gel electrophoresis of membrane enzymes with detergents. Methods Enzymol (1974) 1.17
Solubilization and partial purification of steroid sulfatase from rat liver: characterization of estrone sulfatase. Arch Biochem Biophys (1976) 1.16
Peroxisomal defects in neonatal-onset and X-linked adrenoleukodystrophies. Science (1985) 1.15
Leukodystrophies: recent developments in genetics, molecular biology, pathogenesis and treatment. Curr Opin Neurol (2001) 1.15
Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer (2001) 1.15
Plasma and red blood cell fatty acids in peroxisomal disorders. Neurochem Res (1999) 1.11
Identification of a fatty acid delta6-desaturase deficiency in human skin fibroblasts. J Lipid Res (2001) 1.10
Chloroplast RNA-binding and pentatricopeptide repeat proteins. Biochem Soc Trans (2004) 1.10
Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas. Brain Res (1998) 1.09
Expression of different combinations of interleukins by human T cell leukemic cell lines that are clonally related. J Exp Med (1989) 1.09
Altered expression of ALDP in X-linked adrenoleukodystrophy. Am J Hum Genet (1995) 1.08
Peroxisomal bifunctional protein deficiency revisited: resolution of its true enzymatic and molecular basis. Am J Hum Genet (1999) 1.08
Ceramidase deficiency in Farber's disease (lipogranulomatosis). Science (1972) 1.08
Hyperuricemia in Down's syndrome. J Clin Endocrinol Metab (1968) 1.07
Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy. Mol Genet Metab (1999) 1.07
A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients. Ann Neurol (1987) 1.06
Adrenoleukodystrophy: impaired oxidation of long chain fatty acids in cultured skin fibroblasts an adrenal cortex. Biochem Biophys Res Commun (1981) 1.06
Use of B-mode ultrasound for visceral fat mass evaluation: comparisons with magnetic resonance imaging. Appl Human Sci (1995) 1.05
High concentration of hexacosanoate in cultured skin fibroblast lipids from adrenoleukodystrophy patients. Biochem Biophys Res Commun (1978) 1.05
Familial X-linked Addison disease as an expression of adrenoleukodystrophy (ALD): elevated C26 fatty acid in cultured skin fibroblasts. Neurology (1982) 1.05
Bone marrow transplantation for infantile ceramidase deficiency (Farber disease). Bone Marrow Transplant (2000) 1.05
Nerve conduction studies in adrenomyeloneuropathy. J Neurol Neurosurg Psychiatry (1996) 1.05
A model of cell size regulation. J Theor Biol (1965) 1.04
Diffusion tensor brain MR imaging in X-linked cerebral adrenoleukodystrophy. Neurology (2001) 1.03
Brain lipids, proteolipids, and free amino acids in maple syrup urine disease. J Neurochem (1966) 1.03
New approaches in peroxisomal disorders. Dev Neurosci (1987) 1.03
Development of myelin in inherited disorders of amino acid metabolism. Arch Neurol (1968) 1.02
Dual targeting of phage-type RNA polymerase to both mitochondria and plastids is due to alternative translation initiation in single transcripts. Biochem Biophys Res Commun (2001) 1.01
Peroxisome assembly mutations in humans: structural heterogeneity in Zellweger syndrome. J Cell Physiol (1992) 1.01
Solvent vapor abuse leukoencephalopathy. Comparison to adrenoleukodystrophy. J Neuropathol Exp Neurol (1994) 1.00
Induction of tumor necrosis factor-alpha in the mouse hippocampus following transient forebrain ischemia. J Cereb Blood Flow Metab (1997) 1.00
Identification of 10Sa RNA (tmRNA) homologues from the cyanobacterium Synechococcus sp. strain PCC6301 and related organisms. Biochim Biophys Acta (1998) 1.00